MRI-focused ultrasound study of blood-brain barrier in low-grade glioma
Part of Brain & nervous system, Cancer clinical trials.
This study uses special imaging during routine MRI scans to check how well the blood-brain barrier lets substances pass in people with low-grade brain tumors. It may help researchers better measure and track treatment effects over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a low-grade glioma and are already getting routine, repeated MRI scans for monitoring.
- You should not have a diagnosis of mild cognitive impairment or worse due to cognitive decline.
- You must not have cognitive ratings that fall between mild and moderate dementia (Clinical Dementia Rating 0.5 to 2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether focused ultrasound can safely open the blood-brain barrier to help your chemotherapy work better. It is for people with glioblastoma who have already completed standard surgery and chemo-radiation and are now on maintenance chemo.
This trial tests whether using focused ultrasound to temporarily open the blood-brain barrier can help chemotherapy (temozolomide) reach a brain tumor called diffuse midline glioma more effectively. The goal is to see if this procedure is safe and feasible in patients who have already completed radiation therapy.
This study tests how low-power focused ultrasound changes brain signals measured during MRI. You may help researchers understand how ultrasound can affect brain activity, even if you don’t have a known brain condition.
This trial uses low-intensity focused ultrasound (LIFU) and brain scans to see how it affects thinking. It may help researchers find new ways to treat brain conditions.
This study looks at using focused ultrasound to temporarily loosen the brain’s “blood barrier” around certain brain tumors, while people still get standard surgery. It aims to help doctors learn how safe the approach is and collect blood/fluid samples during the operation.
This trial tests whether a special ultrasound (LIFU) can open the blood-brain barrier to help an immunotherapy drug (cetuximab) reach glioblastoma tumors better. It is for people with a specific type of glioblastoma that has not been treated yet and that has a certain protein called EGFR.
Hear when a new Low Grade Glioma of Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.